4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Verrica Pharmaceuticals Inc. (VRCA) operates in the Biotechnology industry and is headquartered in West Chester, United States with about 76 employees. Its market capitalization is roughly $112 million. In the fiscal year ended 2025-12-31, VRCA reported $36M in revenue and ($18M) in net income.
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.
Interactive charts & full statements → Open the VRCA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $36M | $8M | $5M | $9M | — |
| Gross Profit | $32M | $5M | $4M | $8M | — |
| Operating Income (EBIT) | ($12M) | ($66M) | ($63M) | ($21M) | — |
| Net Income | ($18M) | ($77M) | ($67M) | ($24M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $5M | $5M | $14M | $13M | $3M | — |
| Gross Profit | $4M | $4M | $13M | $12M | $3M | — |
| Operating Income (EBIT) | ($10M) | ($7M) | $2M | $2M | ($8M) | — |
| Net Income | ($10M) | ($8M) | ($0M) | $0M | ($10M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $47M | $54M | $82M | $45M | — |
| Total Liabilities | $22M | $64M | $62M | $5M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VRCA viewer.
About TickerBase · Data methodology & sources